Symptoms and treatment of dientomoebo frogilis infection in children, a retrospective study

Pediatric Infectious Disease Journal

Volumn 32, Issue 4, 2013, Pages

  Ter Schure, Janna M A ^a   De Vries, Marrit ^b   Weel, Jan F L ^c   Van Roon, Eric N ^c   Faber, Tina E ^c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Clioquinol; Dientamoeba; Metronidazole; Parasitic infection

Indexed keywords

CLIOQUINOL; METRONIDAZOLE; ANTIPROTOZOAL AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DIENTAMOEBA; DIENTAMOEBIASIS; DRUG EFFICACY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THERAPY EFFECT; VOMITING; WEIGHT REDUCTION; FECES; INFANT; NETHERLANDS; PARASITOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; CLIOQUINOL; DIENTAMOEBIASIS; FECES; FEMALE; HUMANS; INFANT; MALE; METRONIDAZOLE; NETHERLANDS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84876288907     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31827f4c20     Document Type: Article

References (20)

1. Jepps MW. Dientamoeba fragilis n.g.,n. sp., a new intestinal amoeba from man. Parasitol. 1918;10:352-367.
2. Johnson EH, Windsor JJ, Clark CG. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev. 2004;17:553-570, table of contents.
3. Cacciò SM, Sannella AR, Manuali E, et al. Pigs as natural hosts of Dientamoeba fragilis genotypes found in humans. Emerging Infect Dis. 2012;18:838-841.
4. Borody TJ. Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol. 2002;17:A103.
5. Bosman DK, Benninga MA, van de Berg P, et al. Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children. Ned Tijdschr Geneeskd. 2004;148:575-579.
6. Cuffari C, Oligny L, Seidman EG. Dientamoeba fragilis masquerading as allergic colitis. J Pediatr Gastroenterol Nutr. 1998;26:16-20.
7. Stark D, Beebe N, Marriott D, et al. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol. 2005;43:2718-2723.
8. Kurt O, Girginkardesler N, Balcioglu IC, et al. Acomparisonofmetronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect. 2008;14:601-604.
9. Preiss U, Ockert G, Broemme S, et al. On the clinical importance of Dientamoeba fragilis infections in childhood. J Hyg Epidemiol Microbiol Immunol. 1991;35:27-34.
10. Vandenberg O, Souayah H, Mouchet F, et al. Treatment of Dientamoeba fragilis infection with paromomycin. Pediatr Infect Dis J. 2007;26:88-90.
11. Stark D, Barratt J, Roberts T, et al. Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. Eur J Clin Microbiol Infect Dis. 2010;29:411-416.
12. Calderaro A, Gorrini C, Montecchini S, et al. Evaluation of a real-time polymerase chain reaction assay for the detection of Dientamoeba fragilis. Diagn Microbiol Infect Dis. 2010;67:239-245.
13. Bruijnesteijn van Coppenraet LE, Wallinga JA, Ruijs GJ, et al. Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy. Clin Microbiol Infect. 2009;15:869-874.
14. Chan FT, Guan MX, Mackenzie AM, et al. Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole. Antimicrob Agents Chemother. 1994;38:1157-1160.
15. Girginkardesler N, Coskun S, Cúneyt Balcioglu I, et al. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect. 2003;9:110-113.
16. Stumpel OFB. Dientamoeba fragilis, vooral bij kinderen pathogeen? Tijdschrift Voor Infectieziekten. 2006;1:155-159.
17. Lagacé-Wiens PR, VanCaeseele PG, Koschik C. Dientamoeba fragilis: an emerging role in intestinal disease. CMAJ. 2006;175:468-469.
18. Grendon JH, DiGiacomo RF, Frost FJ. Descriptive features of Dientamoeba fragilis infections. J Trop Med Hyg. 1995;98:309-315.
19. Ayadi A, Bahri I. Dientamoeba fragilis: pathogenic flagellate?. Bull Soc Pathol Exot. 1999;92:299-301.
20. Stark D, Barratt J, Roberts T, et al. A review of the clinical presentation of dientamoebiasis. Am J Trop Med Hyg. 2010;82:614-619.